The Effects of the Introduction of Medication On the Psychoanalytic Process: A Case Study

Journal of the American Psychoanalytic Association

Volumn 49, Issue 2, 2001, Pages 607-627

  Greene, Marshall A ^a  

^a San Francisco Center for Psychoanalysis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE;

ADULT; ANXIETY DISORDER; ARTICLE; CASE REPORT; DEFENSE MECHANISM; DEPRESSION; FEMALE; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PSYCHOANALYSIS; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; SUPEREGO; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; COMBINED MODALITY THERAPY; DEFENSE MECHANISMS; DEPRESSION; FEMALE; FLUOXETINE; HUMANS; PSYCHOANALYTIC THERAPY; PSYCHOTHERAPEUTIC PROCESSES; SUPEREGO; TREATMENT OUTCOME;

EID: 0035289050     PISSN: 00030651     EISSN: None     Source Type: Journal    
DOI: 10.1177/00030651010490020901     Document Type: Editorial

References (11)

1. Abel-Horowitz, J. (1998). Psychopharmacotherapy during an analysis. Psychoanalytic Inquiry 18: 673–701.
2. Aberg-Wistedt, A. (1989). The antidepressant effects of 5-HT uptake inhibitors. British Journal of Psychiatry 155(suppl. 8):32–40.
3. Cabaniss, D. (1998). Shifting gears. Psychoanalytic Inquiry 18: 639–656.
4. Cleare, A.J., & Bond, A.J. (1997). Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects. Psychiatry Research 69: 89–95.
5. Eissler, K.R. (1953). The effect of the structure of the ego on psychoanalytic technique. Journal of the American Psychoanalytic Association 1: 104–143.
6. Fuller, R.W. (1996). The influence of fluoxetine on aggressive behavior. Neuropsycho-pharmacology 14: 77–81.
7. Roose, S., & Johannet, C. (1998). Medication and psychoanalysis: Treatments in conflict. Psychoanalytic Inquiry 18: 606–620.
8. Roose, S. & Stern, R. (1993). Medication use in training cases: A survey. Journal of the American Psychoanalytic Association 43: 163–170.
9. Weinshel, E. (1984). Some observations on the analytic process. Psychoanalytic Quarterly 53: 63–84.
10. Willick, M. (1992). Introduction to the panel on the use of medication with patients in analysis. Journal of Clinical Psychoanalysis 1: 11–13.
11. Wylie, H., & Wylie, M. (1995). Resistances and obstructions: Their distinction in psychoanalytic treatment. Journal of Clinical Psychoanalysis 4: 185–207.